LighthouseTM Medical Emergency Medication:
Epinephrine 1 mg/mL (1:1000)
Guidelines have been established to help doctors and staff members adequately prepare for the immediate and effective management of life-threatening situations.
With HANSAmed being the sole provider and distributor of LIGHTHOUSETM across Canada, we have developed different solutions to accommodate all dental clinical medical emergency needs.
1 mg/mL: Used in the emergency treatment of allergic reactions including anaphylaxis, which may result from allergic reactions to insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
The signs and symptoms associated with anaphylaxis include flushing, apprehension, syncope, tachycardia, unobtainable pulse associated with hypotension, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, airway swelling, laryngospasm, bronchospasm, pruritus, angioedema, swelling of the eyelids, lips, and tongue.
1 mL single-use vials contains 1 mL epinephrine injection, USP solution (1:1000) in a glass vial.
Epinephrine is light sensitive. Protect from light and freezing.
Inspect visually for particulate matter and discoloration prior to administration. Do not use the solution if it is colored or cloudy, or if it contains particulate matter.
The LIGHTHOUSETM medical emergency kit is a lifesaving investment and includes epinephrine vials in the LIGHTHOUSETM basic medical emergency kit and LIGHTHOUSETM medical emergency kit
Epinephrine 1mg/mL single-use vial, while it does not contain chlorobutanol, must be diluted before intraocular use.
Incorrect Locations of Injection:
Injection into the anterolateral aspect of the thigh (vastus lateralis muscle) is the most appropriate location for administration because of its location, size, and available blood flow. Injection into (or near) smaller muscles, such as in the deltoid, is not recommended due to possible differences in absorption associated with this use.
- Do not administer repeated injections of epinephrine at the same site, as the resulting vasoconstrictionmay cause tissue necrosis.
- Do not inject into buttock:
- Injection into the buttock may not provide effective treatment of anaphylaxis.
- Do not inject into digits, hands, or feet:
- Epinephrine is a strong vasoconstrictor. Accidental injection into the digits, hands or feet may result in loss of blood flow to the affected area and has been associated with tissue necrosis.
Information was retrieved from: